While there is a whole host of viruses going around, there are thankfully no new viruses to fret about—the ones we have are ...

Hospital visits in Illinois due to flu are "quite high," with COVID and RSV also circulating. But what are the symptoms of ...

In the wake of multiple cases of human metapneumovirus (hMPV) in India, multiple questions about its causes and symptoms seem ...

For most people RSV is like a cold, but for infants and older people it can lead to serious infections. Here's what to know.

Nirsevimab is protective against RSV infections and coinfections, which suggests there is no replacement of RSV with other viruses post-nirsevimab administration.

Some hospitals in the U.S. are seeing an increase in cases of RSV and so-called "walking pneumonia." Here's what you need to know. A rise in rates of sudden unexpected infant deaths may have been ...

Shionogi’s oral antiviral for respiratory syncytial virus (RSV) has met its primary endpoint in a Phase II study.

While RSV isn’t any more virulent than the cold, flu or COVID, the same precautions are recommended in order to control its ...

Pregnant women across Australia will be offered a free vaccine to protect their babies against respiratory syncytial virus (RSV) from next month. The government's $174.5 million investment will ensure ...

As we head into the peak of 2025 RSV season, parents are once again facing an uptick in cases, with health experts warning ...

RSV is the most common cause of bronchiolitis and pneumonia in children younger than 1 year of age, the CDC said. RSV leads to 58,000–80,000 hospitalizations among children younger than 5 years ...